AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

Post on 06-Jul-2018

221 views 0 download

Transcript of AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    1/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    2/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    3/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    4/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    5/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    6/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    7/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    8/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    9/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    10/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    11/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    12/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    13/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    14/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    15/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    16/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    17/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    18/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    19/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    20/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    21/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    22/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    23/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    24/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    25/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    26/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    27/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    28/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    29/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    30/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    31/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    32/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    33/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    34/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    35/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    36/37

  • 8/17/2019 AFHSC Neuropsychiatric Adverse Events Following Mefloquine Exposure slide show

    37/37